these novel synthetic inhibitors , specific for egf-receptor kinase , offer a new method to inhibit egf-stimulated cell proliferation which may be useful in treating specific pathological conditions involving cellular proliferation , including different types of cancers .
C0030660
pathological conditions
C0020507
cellular proliferation